|Articles|April 1, 2013
- Pharmaceutical Executive-04-01-2013
- Volume 0
- Issue 0
PE, April 2013 Cover Image
S
Advertisement
Cover
Articles in this issue
about 13 years ago
Country Report: Belgiumabout 13 years ago
On-Market Pricing Strategiesabout 13 years ago
Is National Drug Pricing Freedom in Europe Nearing its Expiry Date?about 13 years ago
Evidence-Based Marketing: From Rise to Stall—and Ultimate Triumphabout 13 years ago
Pfizer's Quality by Design Approach to Trial Managementabout 13 years ago
Woman of the Year 2013about 13 years ago
Key to Brand Positioning: Look Inside Your Heartabout 13 years ago
Full Disclosure for PharmaNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Asembia ASX26: Adjusting Strategies to Adapt to an Uncertain Global Political and Regulatory Market
2
Which Supply Chains are Most Exposed by Disruptions in The Strait of Hormuz?
3
Teva Enters $900 Million Agreement to Acquire Emalex
4
Pharmaceutical Risks in the Strait of Hormuz
5